Internal Medicine, Infectious Disease · Saint Louis, MO
NPI
1508421629
Since 2019
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1201 S Grand Blvd
Saint Louis, MO, 63104
Phone (314) 257-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,087
109 services
Medicare patients, 2024
50
Average age 64
Drug cost, 2024
$1.5M
529 prescriptions
Company payments, 2025
$780
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin J Robertson was code 99232 (hospital e&m - subsequent), 61 times for 26 patients. In total Kevin J Robertson billed 109 services in 9 codes, and Medicare paid $8,087.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 61 | 26 | $60.26 | $3,676 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 13 | $90.65 | $1,994 |
| 99215 Office E&M - Established | Facility | 12 | 11 | $103.85 | $1,246 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin J Robertson prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 226 prescriptions and refills. In total Kevin J Robertson wrote 529 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 226 | 226 | 34 | $950K |
| Tivicay Dolutegravir Sodium | 47 | 47 | Under 11 | $127K |
| Prezcobix Darunavir/Cobicistat | 29 | 29 | Under 11 | $82K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 19 | Under 11 | $155 |
| Atorvastatin Calcium Generic | 18 | 26 | Under 11 | $17.35 |
| Juluca Dolutegravir/Rilpivirine | 15 | 15 | Under 11 | $52K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 14 | 14 | Under 11 | $58K |
| Norvir Ritonavir | 13 | 13 | Under 11 | $3,330 |
| Prezista Darunavir | 13 | 13 | Under 11 | $15K |
| Rukobia Fostemsavir Tromethamine | 11 | 11 | Under 11 | $105K |
Brand drugs: 414 claims; generic drugs: 115 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin J Robertson $780 ($780 in general payments such as food, travel and fees) from 3 companies. The largest payer was ViiV Healthcare Company with $364.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.